Bracket Acquires Clintara

Published on: 

Applied Clinical Trials

Bracket Global, and Clintara announced the two companies have agreed to combine.

 

Bracket Global, and Clintara announced the two companies have agreed to combine. Bracket will integrate the Clintara platform of surveillance strategies developed for clinical trials within Bracket's proprietary electronic platform for Clinical Outcome Assessments (eCOA). The integration will include Clintara's innovative C-VISA Subject Eligibility Validation program designed to ensure appropriate patients are enrolled in clinical trials. 

Advertisement